European Respiratory Journal

The ERJ publishes clinical and experimental work relating to all aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine and thoracic surgery. In addition to original research material, the ERJ also publishes editorial commentaries, reviews, short research letters and correspondence to the editor. Articles are published continuously and collected into 12 monthly issues in two volumes per year.

February

ERJ Podcast Eur Respir J 2011; 37: E2
Titanium and gold nanoparticles in asthma: the bad and the ugly Lanone S., Boczkowski J. Eur Respir J 2011; 37: 225
The promise of electronic data capture in respiratory medicine Johnston N., O'Byrne P., Kolb M. Eur Respir J 2011; 37: 228
Daytime predictors of sleep-disordered breathing in neuromuscular patients to better schedule polysomnography Lofaso F., Fauroux B., Orlikowski D., Prigent H. Eur Respir J 2011; 37: 231
The case for inspiratory muscle training in COPD Ambrosino N. Eur Respir J 2011; 37: 233
The case against inspiratory muscle training in COPD Polkey M.I., Moxham J., Green M. Eur Respir J 2011; 37: 236
Vitamin D status and longitudinal lung function decline in the Lung Health Study Kunisaki K.M., Niewoehner D.E., Singh R.J., Connett J.E. Eur Respir J 2011; 37: 238
Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways Cortijo J., Mata M., Milara J., Donet E., Gavaldà A., Miralpeix M., Morcillo E.J. Eur Respir J 2011; 37: 244
Candidate genes for COPD in two large data sets Bakke P.S., Zhu G., Gulsvik A., Kong X., Agusti A.G.N., Calverley P.M.A., Donner C.F., Levy R.D., Make B.J., Paré P.D., Rennard S.I., Vestbo J., Wouters E.F.M., Anderson W., Lomas D.A., Silverman E.K., Pillai S.G. Eur Respir J 2011; 37: 255
Symptom variability in patients with severe COPD: a pan-European cross-sectional study Kessler R., Partridge M.R., Miravitlles M., Cazzola M., Vogelmeier C., Leynaud D., Ostinelli J. Eur Respir J 2011; 37: 264
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison Kornmann O., Dahl R., Centanni S., Dogra A., Owen R., Lassen C., Kramer B. Eur Respir J 2011; 37: 273
Health-related quality of life and functional status in end-stage COPD: a longitudinal study Habraken J.M., van der Wal W.M., ter Riet G., Weersink E.J.M., Toben F., Bindels P.J.E. Eur Respir J 2011; 37: 280
Significant increase of CD57+ cells in pulmonary lymphoid follicles of COPD patients Olloquequi J., Montes J.F., Prats A., Rodríguez E., Montero M.A., García-Valero J., Ferrer J. Eur Respir J 2011; 37: 289
Lung exposure to nanoparticles modulates an asthmatic response in a mouse model Hussain S., Vanoirbeek J.A.J., Luyts K., De Vooght V., Verbeken E., Thomassen L.C.J., Martens J.A., Dinsdale D., Boland S., Marano F., Nemery B., Hoet P.H.M. Eur Respir J 2011; 37: 299
A mobile telephone-based interactive self-care system improves asthma control Liu W-T., Huang C-D., Wang C-H., Lee K-Y., Lin S-M., Kuo H-P. Eur Respir J 2011; 37: 310
Exercise is associated with improved asthma control in adults Dogra S., Kuk J.L., Baker J., Jamnik V. Eur Respir J 2011; 37: 318
Combined exposure to dog and indoor pollution: incident asthma in a high-risk birth cohort Carlsten C., Brauer M., Dimich-Ward H., Dybuncio A., Becker A.B., Chan-Yeung M. Eur Respir J 2011; 37: 324
Osteopontin expression and relation to disease severity in human asthma Samitas K., Zervas E., Vittorakis S., Semitekolou M., Alissafi T., Bossios A., Gogos H., Economidou E., Lötvall J., Xanthou G., Panoutsakopoulou V., Gaga M. Eur Respir J 2011; 37: 331
Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma Schmitt L., Wiebel M., Frese F., Dehnert C., Zugck C., Bärtsch P., Mairbäurl H. Eur Respir J 2011; 37: 342
Increased Rho-kinase expression and activity and pulmonary endothelial dysfunction in smokers with normal lung function Duong-Quy S., Dao P., Hua-Huy T., Guilluy C., Pacaud P., Dinh-Xuan A.T. Eur Respir J 2011; 37: 349
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Song J.W., Hong S-B., Lim C-M., Koh Y., Kim D.S. Eur Respir J 2011; 37: 356
Procedure volume is one determinant of centre effect in mechanically ventilated patients Darmon M., Azoulay E., Fulgencio J-P., Garrigues B., Gouzes C., Moine P., Villers D., Teboul V., le Gall J-R., Chevret S. Eur Respir J 2011; 37: 364
Usefulness of serum procalcitonin levels in pulmonary tuberculosis Ugajin M., Miwa S., Shirai M., Ohba H., Eifuku T., Nakamura H., Suda T., Hayakawa H., Chida K. Eur Respir J 2011; 37: 371
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis Su W-J., Feng J-Y., Chiu Y-C., Huang S-F., Lee Y-C. Eur Respir J 2011; 37: 376
Prognostic value of procalcitonin in community-acquired pneumonia Schuetz P., Suter-Widmer I., Chaudri A., Christ-Crain M., Zimmerli W., Mueller B. Eur Respir J 2011; 37: 384
Factors associated with inflammatory cytokine patterns in community-acquired pneumonia Martínez R., Menéndez R., Reyes S., Polverino E., Cillóniz C., Martínez A., Esquinas C., Filella X., Ramírez P., Torres A. Eur Respir J 2011; 37: 393
Screening for sleep-disordered breathing in neuromuscular disease using a questionnaire for symptoms associated with diaphragm paralysis Steier J., Jolley C.J., Seymour J., Teschler H., Luo Y.M., Polkey M.I., Moxham J. Eur Respir J 2011; 37: 400
Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1? synthesis by human neutrophils Langereis J.D., Oudijk E-J.D., Schweizer R.C., Lammers J-W.J., Koenderman L., Ulfman L.H. Eur Respir J 2011; 37: 406
Impact of inspiratory muscle training in patients with COPD: what is the evidence? Gosselink R., De Vos J., van den Heuvel S.P., Segers J., Decramer M., Kwakkel G. Eur Respir J 2011; 37: 416
Circulating endothelial progenitor cells and chronic pulmonary diseases Huertas A., Palange P. Eur Respir J 2011; 37: 426
Assessment of problematic severe asthma in children Lødrup Carlsen K.C., Hedlin G., Bush A., Wennergren G., de Benedictis F.M., De Jongste J.C., Baraldi E., Pedroletti C., Barbato A., Malmström K., Pohunek P., Pedersen S., Piacentini G.L., Middelveld R.J.M., Carlsen K.H. Eur Respir J 2011; 37: 432
Treatment of tuberculosis: update 2010 Yew W.W., Lange C., Leung C.C. Eur Respir J 2011; 37: 441
Subsequent COPD and lung cancer in patients with autoimmune disease Hemminki K., Liu X., Ji J., Sundquist K., Sundquist J. Eur Respir J 2011; 37: 463
Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan Ishii H., Tazawa R., Kaneko C., Saraya T., Inoue Y., Hamano E., Kogure Y., Tomii K., Terada M., Takada T., Hojo M., Nishida A., Ichiwata T., Trapnell B.C., Goto H., Nakata K. Eur Respir J 2011; 37: 465
Is NMR-based metabolomic analysis of exhaled breath condensate accurate? Izquierdo-García J.L., Peces-Barba G., Heili S., Diaz R., Want E., Ruiz-Cabello J. Eur Respir J 2011; 37: 468
Hypercalcaemia in asymptomatic sarcoidosis unmasked by a vitamin D loading dose Amrein K., Schilcher G., Fahrleitner-Pammer A. Eur Respir J 2011; 37: 470
Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension Lee W-T.N., Kirkham N., Johnson M.K., Lordan J.L., Fisher A.J., Peacock A.J. Eur Respir J 2011; 37: 472
Liver toxicity of sitaxentan in pulmonary arterial hypertension Galiè N., Hoeper M.M., Gibbs J.S.R., Simonneau G. Eur Respir J 2011; 37: 475
Dyspnoea: a prognostic marker for idiopathic pulmonary fibrosis Aggarwal D., Mohapatra P.R. Eur Respir J 2011; 37: 476
From the authors: Nishiyama O., Taniguchi H. Eur Respir J 2011; 37: 476
Non-invasive Ventilation and Weaning: Principles and Practice Ambrosino N. Eur Respir J 2011; 37: 478